LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Frank J. Nice" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Mon, 26 Aug 2013 21:47:06 +0000
Content-Type:
text/plain
Parts/Attachments:
text/plain (30 lines)
Please see my post below to Lactnet on August 3, 2012:
Frank J. NiceEdit profile detailsFrom:Frank J. Nice ([log in to unmask])Sent:Fri 8/03/12 6:54 PMTo: LACTNET ([log in to unmask])



 I just spoke for 1/2 hour with a representative from MedWatch regarding the new Methergine breastfeeding labeling.
 I alerted MedWatch to both my and Tom Hale's recommendations and to Tom's website.
 I explained the need for more breastfeeding pharmacokinetic and pharmacodynamic data and for a comprehensive breastfeeding and medication 
 benefit -risk analysis (see my article) to be included in labeling for breastfeeding and Methergine.
 Evidently, the FDA has received many questions to date from the nursing and breastfeeding community regarding this new labeling.
 It appears critical to continue to contact the FDA as individuals and organizations regarding this issue.
 Thank you.

Frank J. Nice, RPh, DPA, CPHP




 		 	   		  
             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2